oxazolidin-2-one has been researched along with ADDH in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, A; Jahan, S; Kulkarni, G | 1 |
| Cornell, S | 1 |
| Gimbrett, R; Priest, RG; Roberts, M; Steinert, J | 1 |
3 other study(ies) available for oxazolidin-2-one and ADDH
| Article | Year |
|---|---|
Potential serious adverse interactions between linezolid and atomoxetine.
Topics: Acetamides; Anti-Bacterial Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bacterial Infections; Child; Cystic Fibrosis; Drug Interactions; Female; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Propylamines; Sputum | 2012 |
A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
Topics: Abortifacient Agents, Steroidal; Acetamides; Anti-Infective Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Drug Approval; Drug Interactions; Humans; Linezolid; Methylphenidate; Mifepristone; Oxazolidinones; Phytotherapy; United States; United States Food and Drug Administration | 2000 |
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Topics: Alzheimer Disease; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Benzamides; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Panic Disorder; Phobic Disorders; Piperidines | 1995 |